Cancer-related multiple gene mutation/mRNA expression IVD, kit, nucleic acid technique (NAT)
United Kingdom·In Vitro Diagnostic Device·Caris MPI, Inc. D/B/A Caris Life Sciences·Registered Nov 26, 2024- Device ID
- 131951
- MHRA Reference Number
- 131951
- Date Registered
- Nov 26, 2024
- Last Updated
- Nov 7, 2024
- Device Type
- In Vitro Diagnostic Device
- Devices
- Cancer-related multiple gene mutation/mRNA expression IVD, kit, nucleic acid technique (NAT)
- Type
- IVD General
- Address
- 4610 South 44th Place Phoenix, Arizona, United States
- Created Date
- Jan 11, 2022
- Relationship Type
- UK Responsible Person
- Address
- Beaver House, 23-38 Hythe Bridge Street Oxford, England, United KingdomPostcode: OX1 2EP
Devices with a matching generic name or device type registered with MHRA
Additional devices represented by MT Promedt Consulting Ltd in the UK
Cancer-related multiple gene mutation/mRNA expression IVD, kit, nucleic acid technique (NAT) is a medical device registered with the UK's Medicines and Healthcare products Regulatory Agency (MHRA) under Device ID 131951. The device is manufactured by Caris MPI, Inc. D/B/A Caris Life Sciences from United States, classified as In Vitro Diagnostic Device. The authorized representative in the UK is MT Promedt Consulting Ltd.
This page provides comprehensive regulatory information including complete registration details, manufacturer information, device classification, authorized representative details, and related products. Pure Global AI offers free access to 150,962+ UK MHRA medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.